Volume 84, Issue 1, Pages (July 2013)

Slides:



Advertisements
Similar presentations
LDL cholesterol in CKD—to treat or not to treat?
Advertisements

Chronic Pain in End-Stage Renal Disease
Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis  Suetonia C. Palmer, MBChB,
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward  Adeera Levin, Paul E. Stevens  Kidney International 
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient  Christoph Wanner,
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta-Analysis  Emmilia A. Dowlatshahi,
Volume 84, Issue 5, Pages (November 2013)
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
The risk of hospitalization and modality failure with home dialysis
John P. Middleton, Patrick H. Pun  Kidney International 
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials  Suetonia C. Palmer, PhD, Sharon Gardner, MA, Marcello Tonelli,
Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials  Suetonia C. Palmer,
Chronic Pain in End-Stage Renal Disease
Volume 85, Issue 3, Pages (March 2014)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Steven J. Chadban, Natalie D. Staplin  Kidney International 
The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review  Suetonia.
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Metabolic syndrome and chronic kidney disease in Okinawa, Japan
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials  Valeria M.S.
Volume 84, Issue 5, Pages (November 2013)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 68, Issue 5, Pages (November 2005)
Volume 70, Issue 11, Pages (December 2006)
Sankar D. Navaneethan, MD, MPH, Suetonia C. Palmer, MBChB, Jonathan C
The epidemiology of chronic kidney disease
Use of vitamin D in chronic kidney disease patients
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
LDL cholesterol in CKD—to treat or not to treat?
Volume 86, Issue 1, Pages (July 2014)
Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1  Lyndsay S. Baines, John T. Joseph,
Volume 70, Issue 12, Pages (December 2006)
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Volume 76, Issue 11, Pages (December 2009)
Volume 73, Issue 12, Pages (June 2008)
A physician's perseverance uncovers problems in a key nephrology study
Volume 81, Issue 10, Pages (May 2012)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Methods for guideline development
Volume 76, Issue 1, Pages (July 2009)
The global challenge of chronic kidney disease
Volume 80, Issue 6, Pages (September 2011)
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Volume 73, Issue 8, Pages (April 2008)
Trial Quality in Nephrology: How Are We Measuring Up?
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Vitamin D in chronic kidney disease: is the jury in?
Cardio-Kidney-Damage: a unifying concept
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia  David E. Leaf, David S. Goldfarb  Kidney.
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Volume 83, Issue 5, Pages (May 2013)
The Danish Renal Biopsy Register
Volume 85, Issue 6, Pages (June 2014)
Volume 75, Issue 1, Pages (January 2009)
Volume 59, Issue 5, Pages (May 2001)
Membranous nephropathy: recent travels and new roads ahead
Dana V. Rizk, David G. Warnock  Kidney International 
The international realities of live donor kidney transplantation
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials  Suetonia C. Palmer, PhD, Sharon Gardner, MA, Marcello Tonelli,
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
O.M. Gutiérrez, T. Isakova, D.L. Andress, A. Levin, M. Wolf 
Global trends in the rates of living kidney donation
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Volume 84, Issue 1, Pages 179-191 (July 2013) Prevalence of depression in chronic kidney disease: systematic review and meta- analysis of observational studies  Suetonia Palmer, Mariacristina Vecchio, Jonathan C. Craig, Marcello Tonelli, David W. Johnson, Antonio Nicolucci, Fabio Pellegrini, Valeria Saglimbene, Giancarlo Logroscino, Steven Fishbane, Giovanni F.M. Strippoli  Kidney International  Volume 84, Issue 1, Pages 179-191 (July 2013) DOI: 10.1038/ki.2013.77 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Flowchart showing number of citations retrieved by database searching and the number and type of studies included in this review. BDI, Beck Depression Inventory; CES-D, Center for Epidemiological Studies Depression Scale; HADS, Hospital Anxiety and Depression Scale; Hamilton, Hamilton Depression Scale; WHO, World Health Organization. Numbers in lower boxes may not add to total number of unique study populations (n=249) when specific data were unavailable in individual studies. Kidney International 2013 84, 179-191DOI: (10.1038/ki.2013.77) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Risk of bias in included studies (n=216). For each quality item: ‘Low risk of bias’ means that sufficient data were reported in the study to allow the assessment of quality and fulfilled the criteria for the quality item; ‘High risk of bias’ means that sufficient data were reported in the study to assess quality but did not fulfill the criteria for the quality item; and ‘Partial risk of bias’ means that incomplete data for the quality item were reported; the study had intermediate risk of bias. CI, confidence interval; CKD, chronic kidney disease. Kidney International 2013 84, 179-191DOI: (10.1038/ki.2013.77) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Prevalence of syndromal depression diagnosed by clinical interview according to specified diagnostic criteria. Summary prevalence of depression identified by interview in people with chronic kidney disease (any stage) ordered by weight and summarized using random-effects meta-analysis. CI, confidence interval; CKD, chronic kidney disease stages 1–5. Kidney International 2013 84, 179-191DOI: (10.1038/ki.2013.77) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Prevalence of depressive symptoms in people with chronic kidney disease stage 5D. CI, confidence interval; BDI, Beck Depression Inventory; CES-D, Center for Epidemiological Studies Depression Scale; HADS, Hospital Anxiety and Depression Scale; Hamilton, Hamilton Depression Scale. Kidney International 2013 84, 179-191DOI: (10.1038/ki.2013.77) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Prevalence of depressive symptoms in people with chronic kidney disease stages 1–5. CI, confidence interval. Kidney International 2013 84, 179-191DOI: (10.1038/ki.2013.77) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Prevalence of depressive symptoms in kidney transplant recipients. CI, confidence interval. Kidney International 2013 84, 179-191DOI: (10.1038/ki.2013.77) Copyright © 2013 International Society of Nephrology Terms and Conditions